Skip to main content
AbClon Inc. logo

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 254 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 91% confidence The document is a voluntary corporate disclosure announcing the signing of a single sales and supply contract, detailing contract parties, amounts, dates, and terms. It is not a financial report, management discussion, or share transaction, nor a proxy or dividend notice. It falls under miscellaneous regulatory announcements and therefore is classified as a Regulatory Filing (RNS).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 97% confidence The document is identified as a 분기보고서 (Korean Quarterly Report) for the 17th fiscal period, covering 2026/01/01–2026/03/31. It contains actual business overviews, company information, and detailed narrative consistent with a full interim/quarterly financial report (including financial period dates and substantive content) rather than a mere announcement. Therefore, it matches the definition for an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-07 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-05-07 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document text indicates a change in the company's department affiliation from '중견기업부' (Mid-sized Enterprise Division) to '벤처기업부' (Venture Enterprise Division) with a reason related to meeting venture regular requirements. This is an announcement about a change in the company's classification or affiliation within a regulatory or stock exchange context. It does not contain financial data, management changes, or meeting information. It is a regulatory announcement about company status change, which fits best under Regulatory Filings (RNS). The document is very short and does not represent a full report or detailed filing.
2026-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.